Great time together with the reunited Miorg! Happy 2024!🎊🧧

It was a pleasure to start the Spring 2024 Immunology Seminar Series with Joris van der Veeken talking about transcriptional regulation T cell activation states. Thank you, Joris! InFLAMES Flagship TurkuBioscience SSI ySSI Suomen Akatemia | Research Council of Finland Turun yliopisto - University of Turku

Our researchers Saara Koskela and Besmir Hyseni have been selected as finalists in the Three minute thesis competition. So on March 6 it is time to cheer on Saara and Besmir 🔥 🔥 👏 🎉!! utu.fi/en/news/news/r…

Way to go Saara Koskela 💪🎉😊 utu.fi/en/news/news/r…

Congratulations, Saara Koskela for winning the 3 Minute Thesis competition!!🥇🏆👏🏻👏🏻MIORG (Medical Immuno-Incology Research Group is very proud of you!💎✨Your hard work and dedication to excellence paid off once more!!😃 InFLAMES Flagship TurkuBioscience Turun yliopisto - University of Turku LOORG MIORG (Medical Immuno-Incology Research Group Finnish Society for Immunology Suomen Akatemia | Research Council of Finland

ImmuDocs Doctoral Education Pilot is coming! Learn more at the seminar next Tuesday March 19th at 15:00 in Turku. This is the place to discuss the ImmuDocs Pilot and meet immunologists from Finnish Universities. See you there! 👉bit.ly/4ah17TH Turun yliopisto - University of Turku Åbo Akademi University

The best of our year 2023: 🔹 We awarded EUR 24 million in grants to medicine. 🔹 We funded 265 researchers or research teams. 🔹 The Brain Gain programme attracts researchers back to Finland. Read more in our article and annual report: sigridjuselius.fi/en/news/sigrid…

I’d the pleasure of representing ⁦Pathological Society⁩ & my research group to explain BAP1’s role in cancer, esp. uveal melanoma, at the Japanese Society of Pathology ⁩ ⁦LOORG⁩ ⁦University of Liverpool⁩ ⁦@LivHospitals⁩ ⁦⁦RC of Pathologists⁩ ⁦

Exciting opportunity: 🔬3-year PhD opportunity in Immuno-Oncology at #miorg_, University of Turku. Join our team to advance treatment for cold tumors. Details: t.ly/3zLPX Apply Here: t.ly/qb07M InFLAMES Flagship University of Liverpool Turun yliopisto - University of Turku Economics UTU

Apply now and do your PhD with us in ImmuDocs! We are hiring 13 Doctoral Researchers who, like us, believe that solution is in immunity. Apply 👉bit.ly/ImmuDocsApply #immunology #PhD Turun yliopisto - University of Turku Åbo Akademi University BioCity Turku TurkuBioscience EFIS yEFIS

Inspiring talk by Prof. Menashe Bar-Eli from MD Anderson Cancer Center on metastatic melanoma. His research helps our group to create new combinatorial immunotherapies and opens collaborative opportunities for our local scientists. Thank you InFLAMES Flagship for your unreserved support!

LOORG

Grateful for the enlightening talk from our collaborator Prof. Tero Aittokallio at FICAN-West Science Day! His work in applied mathematics & bioinformatics is revolutionizing drug predictions for improved disease outcomes. @TurkuBioscience MD Anderson Cancer Center InFLAMES Flagship

New and crucial role discovered for a protein in the body's immunity against cancer inflames.utu.fi/new-and-crucia… via @inflames_health

Science does not advance by regression to the mean (tending to the average). Like evolution there is an outlier that harbors a solution to new challenges. Defend the outlier, despite the pressure of the statistics. That... over time... leads to progress.

SSI Young Investigator Award winners of 2024 are Anne Margrete Troldborg from Denmark, Carlos Rogerio Figueiredo from Finland and Johanne Jacobsen from Norway. Congratulations 💐 #ECI2024

Congratulations Carlos Rogerio Figueiredo and MIORG (Medical Immuno-Incology Research Group🔥👏🔥!

Our warmest congratulations to Dr. Carlos Rogerio Figueiredo for the Young Investigator Award from the Scandinavian Society for Immunology! MIORG (Medical Immuno-Incology Research Group InFLAMES Flagship Carlos Rogerio Figueiredo TurkuBioscience SSI

An excellent resource to our community! nature.com/articles/s4159…

DeepSeek: If people can get answers for less $$, they will just ask more questions. For my lab, this means we can do some remarkable things for cancer research with the AI overlay we've been creating to study the rich interactions of how immune system cells interface with